Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N T Sepp

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Investigative Dermatology|September 1, 1994
Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cellsN T Sepp, L J Li, K H Lee, et al.
The Journal of Investigative Dermatology|April 16, 1998
Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cellsG Weinlich, M Heine, H Stössel, et al.
Clinical and Experimental Rheumatology|June 24, 2005
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetilC N Pisoni, G Obermoser, M J Cuadrado, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Investigative Dermatology|September 1, 1994
Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cellsN T Sepp, L J Li, K H Lee, et al.
The Journal of Investigative Dermatology|April 16, 1998
Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cellsG Weinlich, M Heine, H Stössel, et al.
Clinical and Experimental Rheumatology|June 24, 2005
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetilC N Pisoni, G Obermoser, M J Cuadrado, et al.
Pageof 3